CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 550 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03980028
NCT03980028N/ACompleted
CompareCT.gov

Role of Surgery in Advanced Ovarian Cancer

Institut Claudius Regaud·observational·Posted Jun 10, 2019·Updated Jun 10, 2019

In Brief

An observational study for Ovarian Cancer. Completed, enrolled 550 participants across 1 site.

Detailed Summary

To demonstrate that ultra-radical surgery with multiple visceral resections and high tumor burden prior to surgery independently reduces the survival of patients with advanced ovarian cancer treated with complete cytoreductive surgery.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Cancer
CountriesFrance
CollaboratorsInstitut Bergonié, Institut Paoli-Calmettes, Institut du Cancer de Montpellier - Val d'Aurelle, Hospital Universitario La Paz, Hospital Vall d'Hebron

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 10, 2019
Enrollment StartJan 1, 2018
Primary CompletionJan 1, 2019
Study CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 7.1 years ago